Evidence map›Paper›PMID 37650437›Full record

ArticleAmerican journal of Alzheimer's disease and other dementias

Comparing Lookback Periods to Ascertain Alzheimer's Disease and Related Dementias.

Zachary J Kunicki, Thomas Bayer, Lan Jiang, Melanie L Bozzay, McKenzie J Quinn, Alyssa N De Vito, Sheina Emrani, Sebhat Erqou, John E McGeary, Andrew R Zullo and 6 more

Abstract read
In one paragraph

Article in American journal of Alzheimer's disease and other dementias. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Zachary J KunickiDepartment of Psychiatry & Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA.ORCID 0000-0002-3466-7589
Thomas BayerVA Center of Innovation in Long Term Services, Providence VA Medical Center, Providence, RI, USA.ORCID 0000-0003-1616-0714
Lan JiangVA Center of Innovation in Long Term Services, Providence VA Medical Center, Providence, RI, USA.
Melanie L BozzayWexner Medical Center, The Ohio State University, Columbus, OH, USA.
McKenzie J QuinnVA RR&D Center for Neurorestoration and Neurotechnology, Providence VA Medical Center, Providence, RI, USA.
Alyssa N De VitoDepartment of Psychiatry & Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA.ORCID 0000-0002-4078-3869
Sheina EmraniDepartment of Psychiatry & Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA.
Sebhat ErqouDepartment of Psychiatry & Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA.
John E McGearyDepartment of Psychiatry & Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA.
Andrew R ZulloVA Center of Innovation in Long Term Services, Providence VA Medical Center, Providence, RI, USA.
Matthew S DupreyDepartment of Pharmacy, University of Kentucky, Lexington, KY, USA.
Mriganka SinghVA Center of Innovation in Long Term Services, Providence VA Medical Center, Providence, RI, USA.
Jennifer M PrimackDepartment of Psychiatry & Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA.
Catherine M KelsoVA RR&D Center for Neurorestoration and Neurotechnology, Providence VA Medical Center, Providence, RI, USA.
Wen-Chih WuVA Center of Innovation in Long Term Services, Providence VA Medical Center, Providence, RI, USA.ORCID 0000-0002-2834-2024
James L RudolphVA Center of Innovation in Long Term Services, Providence VA Medical Center, Providence, RI, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Claims data are a valuable resource for studying Alzheimer's disease and related dementias (ADRD). Alzheimer's disease and related dementias is often identified using a list of claims codes and a fixed lookback period of 3 years of data. However, a 1-year lookback or an approach using all-available lookback data could be beneficial based on different research questions. Thus, the purpose of this study was to compare 1-year and all-available lookback approaches to ascertaining ADRD compared to the standard 3-year approach. Using a cohort of Veterans hospitalized for heart failure (N = 373, 897), our results suggested high agreement (93% or greater) between the lookback periods. The 1-year lookback period had lower sensitivity (60%) and underestimated the prevalence of ADRD. These results suggest that 1-year and all-available lookback periods are viable approaches when using claims data.

Indexed as

Alzheimer DiseaseHumansPrevalencealzheimer diseaseclaims datadiagnostic algorithmslookback periodsveterans

Identifiers

PMID37650437
PMCPMC10623942

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.